Role for microRNAs in regulating glucocorticoid response and resistance in multiple myeloma.
Ontology highlight
ABSTRACT: Glucocorticoids (GCs) are widely used in the treatment of hematological malignancies such as multiple myeloma. However, the development of resistance to GCs limits their clinical utility. Response to GCs is dependent on an active glucocorticoid receptor, GR-α, expressed at wild-type levels in the GC-sensitive cell line (MM.1S). GC-resistant derivative cell lines MM.1Re and MM.1RL display significant downregulation of GR-α transcripts. In this study, we report that a luciferase reporter containing the 3'-UTR of GR-α is significantly repressed in MM.1R cells when compared to MM.1S cells, suggesting that one or several microRNAs that are upregulated in MM.1R maybe in part responsible for the downregulation of the GR-α transcript. To examine posttranscriptional mechanisms of GR regulation, we
SUBMITTER: Tessel MA
PROVIDER: S-EPMC3725966 | biostudies-literature | 2011 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA